Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Plos One
|
May 24, 2011
Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial
Delia Bethell, Youry Se, Chanthap Lon, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
April 8, 2014
The use of a prodrug approach to minimize potential CNS exposure of next generation quinoline methanols while maintaining efficacy in in vivo animal models
Jason C Sousa, Erin Milner, Dustin Carroll, et al.
Circulation. Heart Failure
|
February 2, 2019
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates
Teruhiko Imamura, Valluvan Jeevanandam, Gene Kim, et al.
Annals of Neurology
|
July 8, 2022
Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic
Joseph P Steiner, Muzna Bachani, Nasir Malik, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 24, 2024
Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis
Serena Borrelli, Maria Sofia Martire, Anna Stölting, et al.
Cancer Research
|
March 16, 2022
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
Siler H Panowski, Surabhi Srinivasan, Nguyen Tan, et al.
Journal of Medicinal Chemistry
|
August 23, 2011
Structure-activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum
Erin Milner, Sean Gardner, Jay Moon, et al.
JAMA Neurology
|
June 10, 2026
Neurological Manifestations in Adult Survivors of Ebola Virus Disease
Bridgette Jeanne Billioux, Cavan Reilly, Collin van Ryn, et al.
Malaria Journal
|
January 7, 2014
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R Marcsisin, Jason C Sousa, Gregory A Reichard, et al.
Allergy
|
July 9, 2021
Standardisation of allergen products: 4. Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5
Julia Zimmer, Sandra Schmidt, Susanne Kaul, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Plos One
|
May 24, 2011
Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial
Delia Bethell, Youry Se, Chanthap Lon, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
April 8, 2014
The use of a prodrug approach to minimize potential CNS exposure of next generation quinoline methanols while maintaining efficacy in in vivo animal models
Jason C Sousa, Erin Milner, Dustin Carroll, et al.
Circulation. Heart Failure
|
February 2, 2019
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates
Teruhiko Imamura, Valluvan Jeevanandam, Gene Kim, et al.
Annals of Neurology
|
July 8, 2022
Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic
Joseph P Steiner, Muzna Bachani, Nasir Malik, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 24, 2024
Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis
Serena Borrelli, Maria Sofia Martire, Anna Stölting, et al.
Cancer Research
|
March 16, 2022
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
Siler H Panowski, Surabhi Srinivasan, Nguyen Tan, et al.
Journal of Medicinal Chemistry
|
August 23, 2011
Structure-activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum
Erin Milner, Sean Gardner, Jay Moon, et al.
JAMA Neurology
|
June 10, 2026
Neurological Manifestations in Adult Survivors of Ebola Virus Disease
Bridgette Jeanne Billioux, Cavan Reilly, Collin van Ryn, et al.
Malaria Journal
|
January 7, 2014
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R Marcsisin, Jason C Sousa, Gregory A Reichard, et al.
Allergy
|
July 9, 2021
Standardisation of allergen products: 4. Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5
Julia Zimmer, Sandra Schmidt, Susanne Kaul, et al.
Page
of 12